Search research articles
Contact Us
Filters
Showing results (111-120 of 148) with videos related to
Page
of 15
Sort By:
Neurology and Therapy
|
June 8, 2023
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study
Jihad Inshasi, Samar Farouk, Ahmed Shatila, et al.
Archives of Neurology
|
September 10, 2008
Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients
Anu Jacob, Brian G Weinshenker, Ivo Violich, et al.
Health Technology Assessment (Winchester, England)
|
June 23, 2017
A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE)
Michael Absoud, Peter Brex, Olga Ciccarelli, et al.
Neurology
|
December 14, 2020
Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review
Viktoria Papp, Melinda Magyari, Orhan Aktas, et al.
Brain : a Journal of Neurology
|
May 12, 2012
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
Joanna Kitley, M Isabel Leite, Ichiro Nakashima, et al.
Neurology and Therapy
|
May 17, 2025
Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older Patients
Raed Alroughani, Jihad Inshasi, Samar Farouk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 13, 2016
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
Maciej Juryńczyk, George Tackley, Yazhuo Kong, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 22, 2024
Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease
Alessia Bianchi, Rosa Cortese, Ferran Prados, et al.
Brain : a Journal of Neurology
|
November 15, 2017
Clinical presentation and prognosis in MOG-antibody disease: a UK study
Maciej Jurynczyk, Silvia Messina, Mark R Woodhall, et al.
Brain : a Journal of Neurology
|
April 3, 2019
Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
Jacqueline Palace, Dan-Yu Lin, Donglin Zeng, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 148) with videos related to
Sort By:
Page
of 15
Neurology and Therapy
|
June 8, 2023
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study
Jihad Inshasi, Samar Farouk, Ahmed Shatila, et al.
Archives of Neurology
|
September 10, 2008
Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients
Anu Jacob, Brian G Weinshenker, Ivo Violich, et al.
Health Technology Assessment (Winchester, England)
|
June 23, 2017
A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE)
Michael Absoud, Peter Brex, Olga Ciccarelli, et al.
Neurology
|
December 14, 2020
Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review
Viktoria Papp, Melinda Magyari, Orhan Aktas, et al.
Brain : a Journal of Neurology
|
May 12, 2012
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
Joanna Kitley, M Isabel Leite, Ichiro Nakashima, et al.
Neurology and Therapy
|
May 17, 2025
Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older Patients
Raed Alroughani, Jihad Inshasi, Samar Farouk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 13, 2016
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
Maciej Juryńczyk, George Tackley, Yazhuo Kong, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 22, 2024
Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease
Alessia Bianchi, Rosa Cortese, Ferran Prados, et al.
Brain : a Journal of Neurology
|
November 15, 2017
Clinical presentation and prognosis in MOG-antibody disease: a UK study
Maciej Jurynczyk, Silvia Messina, Mark R Woodhall, et al.
Brain : a Journal of Neurology
|
April 3, 2019
Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
Jacqueline Palace, Dan-Yu Lin, Donglin Zeng, et al.
Page
of 15